Evidence map›Paper›PMID 39046230›Full record

ArticlemSphere2024

Clofazimine inhibits innate immunity against

Xinda Li, Xiaoyi Luo, Bin Wang, Lei Fu, Xi Chen, Yu Lu

Abstract read
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xinda Li *Department of Pharmacology, Beijing Chest Hospital, Capital Medical University, Beijing, China.ORCID 0009-0006-8278-9413
Xiaoyi Luo *Department of Pharmacology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Bin WangDepartment of Pharmacology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Lei FuDepartment of Pharmacology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Xi ChenDepartment of Pharmacology, Beijing Chest Hospital, Capital Medical University, Beijing, China.
Yu LuDepartment of Pharmacology, Beijing Chest Hospital, Capital Medical University, Beijing, China.ORCID 0000-0002-9038-1884

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) remains one of the infectious diseases with high incidence and high mortality. About a quarter of the population has been latently infected with IMPORTANCE: The complete elimination of

Indexed as

ClofazimineImmunity, InnateMycobacterium tuberculosisNF-kappa BAnimalsAntitubercular AgentsCytokinesHumansMiceTranscription Factor RelATuberculosisAntitubercular AgentsClofazimineCytokinesNF-kappa BTranscription Factor RelAantitubercular drugimmunomodulationMycobacterium tuberculosispost-tuberculous lung disease

Identifiers

PMID39046230
PMCPMC11351037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.